Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Updates Rating on Array Technologies to Neutral

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finance_Banking (2)
0
SHARES
29
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Mizuho analyst Maheep Mandloi updated their rating on Array Technologies (NASDAQ: ARRY) to Neutral and decreased the price target to $18 from $20. This change in perspective differs from their previous report, where Mandloi had maintained a Neutral rating but raised the price target to $20 from $19. The revised price target suggests a shift in the analyst’s view on the company’s performance. This adjustment comes after Mizuho first covered Array Technologies with a Neutral recommendation in November 2023. In contrast, Mizuho reaffirmed a Buy recommendation for Qualcomm (NASDAQ: QCOM) in August 2023.

ARRY Stock Price Rises 1.79% on February 28, 2024: Investors Cautiously Optimistic

On February 28, 2024, ARRY stock closed at $13.64, marking a $0.24 increase since the previous market close, a 1.79% rise for the day. Despite this increase, ARRY is still trading near the bottom of its 52-week range and below its 200-day simple moving average.

The stock did not experience any significant movement in after-hours trading, remaining unchanged. This stability could indicate that investors are cautiously optimistic about the stock’s performance in the near future.

Investors should continue to monitor the stock’s performance and consider any relevant news or events that may impact its price movement. Overall, the slight uptick in ARRY’s stock price on February 28, 2024, suggests some positive momentum for the company. However, investors should exercise caution and conduct thorough research before making any investment decisions related to ARRY or any other stock.

ARRY Stock Financial Performance: Revenue Decline but Strong Net Income Growth – February 28, 2024 Analysis

On February 28, 2024, ARRY stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $1.58 billion for the past year, which decreased by 3.72% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $341.62 million for Q4.

In terms of net income, ARRY reported a significant increase of 2996.57% since the previous year, with a net income of $137.24 million for the past year. The net income also held flat since the last quarter, with $19.34 million reported for Q4.

Earnings per share (EPS) for ARRY stock showed a positive trend over the past year, with an increase of 292.31% compared to the previous year. The EPS stood at $0.56 for the past year but decreased by 40.6% since the last quarter, with an EPS of $0.04 for Q4.

Overall, ARRY stock showed strong growth in net income and earnings per share over the past year. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth potential.

Tags: ARRY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
AI medical laboratory

Crinetics Pharmaceuticals Secures 350 Million in Private Placement Financing

DrugRetailers Trading online

Vipshops Impressive Q4 Results Drive Surge in Stock Value

Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Anticipating Evergys Financial Results A Look at Past Performance and Future Projections

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com